First-Year experience of chemotherapy for advanced retinoblastoma in Tanzania: Disease profile, outcomes, and challenges in 2008

Journal of Pediatric Ophthalmology and Strabismus

Volumn 49, Issue 3, 2012, Pages 176-183

  Carrim, Zia I ^a   Kajaige, Jane ^b   Bowman, Richard J ^c   Lavy, Tim E ^c,d   Scanlan, Patricia ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b Dar es Salaam ^*  (Tanzania)

^c CCBRT Hospital   (Tanzania)

^d ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CENTRAL NERVOUS SYSTEM METASTASIS; CHILD; CLINICAL ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; LENGTH OF STAY; MALE; MULTIPLE CYCLE TREATMENT; NEWBORN; ORBIT CANCER; PRESCHOOL CHILD; RETINOBLASTOMA; SCHOOL CHILD; TANZANIA; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD; CHILD, PRESCHOOL; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; EYE ENUCLEATION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICAL AUDIT; RETINAL NEOPLASMS; RETINOBLASTOMA; TANZANIA; TERTIARY CARE CENTERS; TREATMENT OUTCOME; VINCRISTINE;

EID: 84862570455     PISSN: 01913913     EISSN: None     Source Type: Journal    
DOI: 10.3928/01913913-20110809-01     Document Type: Article

References (22)

1. Kivela T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129-1131.
2. Central Intelligence Agency. The World factbook: Tanzania. https://www.cia.gov/library/publications/the-world-factbook/geos/tz.html. Accessed June 1, 2010.
3. Bowman RJ, Mafwiri M, Luthert P, Luande J, Wood M. Outcome of retinoblastoma in east Africa. Pediatr Blood Cancer. 2008;50:160-162.
4. The UKCCSG Retinoblastoma Working Group. Guidelines for the management of children with advanced retinoblastoma following primary enucleation (version 1.0). Leicester: UKCCSG: 2005.
5. Shields CL, Shields JA. Retinoblastoma management: advances in enucleation, intravenous chemoreduction, and intra-arterial chemotherapy. Curr Opin Ophthalmol. 2010;21:203-212.
6. Bekibele CO, Ayede AI, Asaolu AA, Brown BJ. Retinoblastoma: the challenges of management in Ibadan, Nigeria. J Paediatr Hematol Oncol. 2009;31:552-555.
7. Wallach M, Balmer A, Munier F, et al. Shorter time to diagnosis and improved stage at presentation in Swiss patients with retinoblastoma treated from 1963 to 2004. Pediatrics. 2006;118:e1493-e1498.
8. Naseripour M, Nazari H, Bakhtiari P, Modarres-zadeh M, Vosough P, Ausari M. Retinoblastoma in Iran: outcomes in terms of patients' survival and globe survival. Br J Ophthalmol. 2009;93:28-32.
9. Boubacar T, Fatou S, Fousseyni T, et al. A 30-month prospective study on the treatment of retinoblastoma in the Gabriel Toure Teaching Hospital, Bamako, Mali. Br J Ophthalmol. 2010;94:467-469.
10. Mwende J, Bronsard A, Mosha M, et al. Delay in presentation to hospital for surgery for congenital and developmental cataract in Tanzania. Br J Ophthalmol. 2005;89:1478-1482.
11. Honavar SG, Singh AD. Management of advanced retinoblastoma. Ophthalmol Clin N Am. 2005;18:65-73.
12. Kim JW, Katpalia V, Dunkel IJ, Wong RK, Riedel E, Abramson DH. Orbital recurrence of retinoblastoma following enucleation. Br J Ophthalmol. 2009;93:463-467.
13. Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT, Maris JM. Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol. 1996;114:1330-1338.
14. Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high risk retinoblastoma. Arch Ophthalmol. 2002;120:923-931.
15. Leal-Leal C, Flores-Rojo M, Medina-Sanson A, et al. A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol. 2004;88:1074-1077.
16. Cozza R, De loris MA, Ilari I, et al. Metastatic retinoblastoma: single institution experience over two decades. Br J Ophthalmol. 2009;93:1163-1166.
17. Gunduz K, Muftuoglu O, Gunalp I, Unal E, Tacyildiz N. Metastatic retinoblastoma: clinical features, treatment and prognosis. Ophthalmology. 2006;113:1558-1566.
18. Shields JA, Shields CL, Meadows AT. Chemoreduction in the management of retinoblastoma. Am J Ophthalmol. 2005;140:505-506.
19. MacCarthy A, Birch JM, Draper GJ, et al. Retinoblastoma in Great Britain 1963-2002. Br J Ophthalmol. 2009;93:33-37.
20. Murphree AL. Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin N Am. 2005;18:41-53.
21. Shields CL, Mashayekhi A, Au AK, et al. The international classification of retinoblastoma predicts chemoreduction success. Ophthalmology. 2006;113:2276-2280.
22. Rodriguez-Galindo C, Wilson MW, Chantada G, et al. Retinoblastoma: one world, one vision. Pediatrics. 2008;122:763-770.